Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs-Reference-Cited by-同舟云学术

Hybrid inhalable microparticles for dual controlled release of levofloxacin and DNase: physicochemical characterization and in vivo targeted delivery to the lungs

Published:2017 Issue:17 Volume:5 Page:3132-3144
ISSN:2050-750X
Container-title:Journal of Materials Chemistry B
language:en
Short-container-title:J. Mater. Chem. B

Author:

Islan G. A.¹²³⁴⁵,Ruiz M. E.⁶⁷³⁸⁵,Morales J. F.⁶⁷³⁸⁵,Sbaraglini M. L.⁹⁷³⁸⁵,Enrique A. V.⁹⁷³⁸⁵,Burton G.¹⁰¹¹¹²¹³⁵,Talevi A.⁹⁷³⁸⁵,Bruno-Blanch L. E.⁹⁷³⁸⁵,Castro G. R.¹²³⁴⁵^ORCID

Affiliation:

1. Laboratorio de Nanobiomateriales

2. CINDEFI – Departamento de Química

3. Facultad de Ciencias Exactas

4. Universidad Nacional de La Plata – CONICET (CCT La Plata)

5. Buenos Aires

6. Cátedra de Control de Calidad de Medicamentos

7. Departamento de Ciencias Biológicas

8. Universidad Nacional de La Plata

9. Laboratorio de Investigación y Desarrollo de Bioactivos (LIDeB)

10. Departamento de Química Orgánica and UMYMFOR (CONICET-UBA)

11. Facultad de Ciencias Exactas y Naturales

12. Universidad de Buenos Aires

13. Ciudad Universitaria

Abstract

Current medical treatments against recurrent pulmonary infections caused by Pseudomonas aeruginosa, such as cystic fibrosis (CF) disorder, involve the administration of inhalable antibiotics.

Funder

Universidad Nacional de La Plata

Consejo Nacional de Investigaciones Científicas y Técnicas

Publisher

Royal Society of Chemistry (RSC)

Subject

General Materials Science,Biomedical Engineering,General Chemistry,General Medicine

Link

http://pubs.rsc.org/en/content/articlepdf/2017/TB/C6TB03366K

Reference49 articles.

1. Cystic fibrosis genetics: from molecular understanding to clinical application

2. Controversies in the Treatment of Early-Stage Hodgkin’s Lymphoma